UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Anxiety Disorders and Temperament—an Update Review

Current psychiatry reports, 2017-05, Vol.19 (5), p.27-27

2017

Volltextzugriff (PDF)

Anxiety Disorders and Temperament—an Update Review

Current psychiatry reports, 2017-05, Vol.19 (5), Article 27

2017

Volltextzugriff (PDF)

Meta-Analysis of Anxiety Disorders and Temperament

Neuropsychobiology, 2014, Vol.69 (3), p.175-186

2014

Volltextzugriff (PDF)

BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression

Psychiatric genetics, 2013-06, Vol.23 (3), p.134-136

2013

Volltextzugriff (PDF)

A cluster model of temperament as an indicator of antidepressant response and symptom severity in major depression

PSYCHIATRY INVESTIGATION, 2014, 11(1), , pp.18-23

2014

Volltextzugriff (PDF)

Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine

Psychiatry research, 2014-08, Vol.218 (3), p.277-283

2014

Volltextzugriff (PDF)

Polymorphisms in ERBB4 and TACR1 associated with dry mouth in clozapine-treated patients

Acta neuropsychiatrica, 2024-04, p.1-6

2024

Volltextzugriff (PDF)

5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression

Neuroreport, 2009-08, Vol.20 (12), p.1125-1128

2009

Volltextzugriff (PDF)

Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine

Journal of clinical psychopharmacology, 2018-06, Vol.38 (3), p.193-199

2018

Volltextzugriff (PDF)

Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients

European neuropsychopharmacology, 2017-05, Vol.27 (5), p.442-449

2017

Volltextzugriff (PDF)

Prevalence of metabolic syndrome in subjects with melancholic and non-melancholic depressive symptoms. A Finnish population-based study

Journal of affective disorders, 2012-02, Vol.136 (3), p.543-549

2012

Volltextzugriff (PDF)

Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression

Neuroscience letters, 2010-06, Vol.477 (3), p.105-108

2010

Volltextzugriff (PDF)

Smoking and weight among patients using clozapine

Nordic journal of psychiatry, 2014-11, Vol.68 (8), p.620-625

2014

Volltextzugriff (PDF)

Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine

Nordic journal of psychiatry, 2017-02, Vol.71 (2), p.89-95

2017

Volltextzugriff (PDF)

Factors associated with subjective side-effects during clozapine treatment

Nordic journal of psychiatry, 2015-04, Vol.69 (3), p.161-166

2015

Volltextzugriff (PDF)

Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine

Nordic journal of psychiatry, 2017, Vol.71 (2)

2017

Volltextzugriff (PDF)

CYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine

BMC psychiatry, 2014-02, Vol.14 (1), p.50-50

2014

Volltextzugriff (PDF)

INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapine

Pharmacogenomics, 2016-12, Vol.17 (18), p.1987-1997

2016

Volltextzugriff (PDF)

P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT

Neuroscience letters, 2011-04, Vol.493 (3), p.127-130

2011

Volltextzugriff (PDF)

One-year follow-up after discontinuing maintenance electroconvulsive therapy

The journal of ECT, 2012-12, Vol.28 (4), p.225

2012

Volltextzugriff (PDF)

Association between vitamin b12 levels and melancholic depressive symptoms: a Finnish population-based study

BMC psychiatry, 2013-05, Vol.13 (1), p.145-145, Article 145

2013

Volltextzugriff (PDF)

BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression

Acta neuropsychiatrica, 2018-06, Vol.30 (3), p.168-174

2018

Volltextzugriff (PDF)

TPH2 polymorphisms may modify clinical picture in treatment-resistant depression

Neuroscience letters, 2009-10, Vol.464 (1), p.43-46

2009

Volltextzugriff (PDF)

Smoking and weight among patients using clozapine

Nordic journal of psychiatry, 2014, Vol.68 (8)

2014

Volltextzugriff (PDF)

Gynaecological Infections as Risk Determinants of Subsequent Cervical Neoplasia

Acta oncologica, 2000, Vol.39 (1), p.71-75

Viikki, Merja

2000

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(36)
Science & Technology
(36)
Humans
(35)
Female
(29)
Middle Aged
(28)
Adult
(27)
Male
(22)
Psychiatry
(22)
Biological And Medical Sciences
(16)
Neurosciences & Neurology
(16)
Aged
(15)
Depressive Disorder, Major - Genetics
(13)
Neurosciences
(13)
Depression
(12)
Medical Sciences
(12)
Clozapine
(10)
Depressive Disorder, Major - Drug Therapy
(9)
Schizophrenia
(8)
Serotonin Uptake Inhibitors - Therapeutic Use
(8)
Temperament
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Anxiety Disorders and Temperament—an Update Review

Anxiety Disorders and Temperament—an Update Review

Meta-Analysis of Anxiety Disorders and Temperament

BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression

A cluster model of temperament as an indicator of antidepressant response and symptom severity in major depression

Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine

Polymorphisms in ERBB4 and TACR1 associated with dry mouth in clozapine-treated patients

5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression

Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine

Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients

Prevalence of metabolic syndrome in subjects with melancholic and non-melancholic depressive symptoms. A Finnish population-based study

Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression

Smoking and weight among patients using clozapine

Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine

Factors associated with subjective side-effects during clozapine treatment

Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine

CYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine

INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapine

P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT

One-year follow-up after discontinuing maintenance electroconvulsive therapy

Association between vitamin b12 levels and melancholic depressive symptoms: a Finnish population-based study

BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression

TPH2 polymorphisms may modify clinical picture in treatment-resistant depression

Smoking and weight among patients using clozapine

Gynaecological Infections as Risk Determinants of Subsequent Cervical Neoplasia

Suchergebnisse filtern